Pascal Turlure

8.2k total citations
113 papers, 3.2k citations indexed

About

Pascal Turlure is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Pascal Turlure has authored 113 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Hematology, 36 papers in Genetics and 26 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Pascal Turlure's work include Acute Myeloid Leukemia Research (52 papers), Hematopoietic Stem Cell Transplantation (29 papers) and Acute Lymphoblastic Leukemia research (24 papers). Pascal Turlure is often cited by papers focused on Acute Myeloid Leukemia Research (52 papers), Hematopoietic Stem Cell Transplantation (29 papers) and Acute Lymphoblastic Leukemia research (24 papers). Pascal Turlure collaborates with scholars based in France, Belgium and United States. Pascal Turlure's co-authors include Sylvie Chevret, Pierre Fenaux, Hervé Dombret, Emmanuel Raffoux, Claude Gardin, Xavier Thomas, Dominique Bordessoule, Oumédaly Reman, Sylvie Castaigné and Cécile Pautas and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Pascal Turlure

109 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pascal Turlure France	25	2.1k	1.2k	955	729	664	113	3.2k
Yoshihisa Kodera Japan	34	2.6k 1.2×	584 0.5×	483 0.5×	664 0.9×	865 1.3×	143	4.1k
Yoichi Takaue Japan	35	2.1k 1.0×	551 0.5×	429 0.4×	528 0.7×	1.3k 1.9×	218	4.1k
Hisashi Gondo Japan	29	1.5k 0.7×	415 0.3×	368 0.4×	347 0.5×	792 1.2×	79	2.9k
Lilian Reich United States	25	1.3k 0.6×	387 0.3×	307 0.3×	202 0.3×	585 0.9×	50	2.2k
Atsushi Wake Japan	26	1.2k 0.6×	446 0.4×	263 0.3×	169 0.2×	656 1.0×	125	2.2k
John A. Liu Yin United Kingdom	20	2.1k 1.0×	833 0.7×	523 0.5×	574 0.8×	650 1.0×	43	2.7k
A Hiraoka Japan	26	1.5k 0.7×	1.0k 0.9×	219 0.2×	576 0.8×	681 1.0×	88	2.8k
Paul V. O’Donnell United States	35	2.6k 1.3×	541 0.5×	472 0.5×	738 1.0×	1.3k 2.0×	121	4.4k
Akihisa Kanamaru Japan	22	661 0.3×	471 0.4×	311 0.3×	125 0.2×	762 1.1×	100	2.4k
Edward Kanfer United Kingdom	26	1.1k 0.5×	229 0.2×	394 0.4×	250 0.3×	477 0.7×	55	1.8k

Countries citing papers authored by Pascal Turlure

Since Specialization

Citations

This map shows the geographic impact of Pascal Turlure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Turlure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Turlure more than expected).

Fields of papers citing papers by Pascal Turlure

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Turlure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Turlure. The network helps show where Pascal Turlure may publish in the future.

Co-authorship network of co-authors of Pascal Turlure

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Turlure. A scholar is included among the top collaborators of Pascal Turlure based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Turlure. Pascal Turlure is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Srour, Micha, Tamim Alsuliman, Julien Labreuche, et al.. (2023). Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). Bone Marrow Transplantation. 58(4). 401–406. 4 indexed citations

Chèze, S., Stéphane Girault, Pascal Turlure, et al.. (2023). Effect of single-unit transfusion in patients treated for haematological disease including acute leukemia: A multicenter randomized controlled clinical trial. Leukemia Research. 129. 107058–107058. 6 indexed citations

Eeltink, Corien, Jacqui Stringer, Paul Bosman, et al.. (2022). Sexual function of adult long-term survivors and their partners after allogeneic hematopoietic cell transplantation in Europe (S-FAST): a study from the Transplant Complications Working Party and Nurses Group of the EBMT. Bone Marrow Transplantation. 58(2). 195–202. 4 indexed citations

Souchet, Laëtitia, Imran Ahmad, Patrice Céballos, et al.. (2020). Complications stomatologiques dans le contexte de l’allogreffe de cellules hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 107(12). S122–S129. 1 indexed citations

Borel, Cécile, Imran Ahmad, Patrice Céballos, et al.. (2020). Prise en charge des complications ophtalmologiques de l’allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 107(12). S116–S121. 1 indexed citations

Woillard, Jean‐Baptiste, Jean Debord, Isabelle Benz‐de Bretagne, et al.. (2017). A Time-Dependent Model Describes Methotrexate Elimination and Supports Dynamic Modification of MRP2/ABCC2 Activity. Therapeutic Drug Monitoring. 39(2). 145–156. 12 indexed citations

Blaise, Didier, Stéphanie Nguyen, Jacques‐Olivier Bay, et al.. (2014). Greffes de cellules souches hématopoïétiques à partir d’un donneur haplo-identique : recommandations de la SFGM-TC (première partie). Pathologie Biologie. 62(4). 180–184. 7 indexed citations

Guillaume, Thierry, Ana Berceanu, A Charbonnier, et al.. (2014). Recommandations de la SFGM-TC concernant l’injection prophylactique, préemptive et curative des lymphocytes du donneur (DLI) après allogreffe de cellules souches hématopoïétiques. Pathologie Biologie. 62(4). 193–196. 11 indexed citations

Beguin, Y, Cécile Borel, Bénedicte Bruno, et al.. (2014). Immunosuppresseurs dans la prévention de la réaction du greffon contre l’hôte : rapport de la SFGM-TC. Pathologie Biologie. 62(4). 197–203. 7 indexed citations

10.

Itzykson, Raphaël, Claude Gardin, Cécile Pautas, et al.. (2011). Impact of post-remission therapy in patients aged 65-70 years with de novo acute myeloid leukemia: a comparison of two concomitant randomized ALFA trials with overlapping age inclusion criteria. Haematologica. 96(6). 837–844. 16 indexed citations

11.

Adès, Lionel, Fabien Le Bras, Charikleia Kelaïdi, et al.. (2011). Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies. Haematologica. 97(2). 213–218. 33 indexed citations

12.

Chevallier, Patrice, Myriam Labopin, Pascal Turlure, et al.. (2011). A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study. Leukemia. 25(6). 939–944. 91 indexed citations

13.

Patron, Vincent, et al.. (2010). Endonasal Trans-Ethmoidal Drainage of a Cerebral Abscess. Skull base. 20(5). 389–392. 4 indexed citations

14.

Vincent‐Fabert, Christelle, Rémi Fiancette, Magali Donnard, et al.. (2008). 5-LOX, 12-LOX and 15-LOX in immature forms of human leukemic blasts. Leukemia Research. 32(11). 1756–1762. 14 indexed citations

15.

Sparsa, A., et al.. (2007). Lymphangite récurrente du membre supérieur d’origine herpétique. La Revue de Médecine Interne. 29(2). 158–160. 2 indexed citations

16.

Taksin, A.-L., Ollivier Legrand, Emmanuel Raffoux, et al.. (2006). High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group. Leukemia. 21(1). 66–71. 226 indexed citations

17.

Réa, Delphine, Laurence Legros, Emmanuel Raffoux, et al.. (2006). High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia. Leukemia. 20(3). 400–403. 46 indexed citations

18.

Reynaud, Stéphane, et al.. (2006). PGE2 receptor subtype functionality on immature forms of human leukemic blasts. Leukemia Research. 30(10). 1309–1313. 14 indexed citations

19.

Bordessoule, Dominique, Jean-Christophe Szelag, Florence Rollé, et al.. (2006). A reverse transcription-nested PCR assay for HHV-6 mRNA early transcript detection after transplantation. Journal of Virological Methods. 134(1-2). 41–47. 14 indexed citations

20.

Gardin, Claude, Pascal Chaı̈bi, Thierry de Revel, et al.. (1997). Intensive chemotherapy with idarubicin, cytosine arabinoside, and granulocyte colony-stimulating factor (G-CSF) in patients with secondary and therapy-related acute myelogenous leukemia. Leukemia. 11(1). 16–21. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact